Generics - Pharmaceutical


Current filters:


Popular Filters

51 to 75 of 442 results

UNITAID helps accessing quality drugs at affordable prices


At an interactive session with Indian pharmaceuticals and diagnostics industry leaders organized by the…


Russian billionaire to acquire control of Veropharm


Roman Avdeev, a well-known Russian banker and one of the country's richest people, has agreed to acquire…

GenericsMergers & AcquisitionsPharmaceuticalVeropharm

Lundbeck files appeal over EC pay-for-delay fine


Denmark-based CNS specialist drugmaker Lundbeck (LUND: CO) has filed its appeal against the European…


Teva to drop development of Nuvigil in bipolar 1 disorder


Israel-based leading generics company Teva Pharmaceutical Industries (NYSE: TEVA) has released disappointing…

armodafinilCephalonGenericsNeurologicalNuvigilPharmaceuticalResearchTeva Pharmaceutical Industries

Endo Health expends $225 million on generic acquisition


USA-based specialty health care company Endo Health Solutions (Nasdaq: ENDP) says that that its Qualitest…

Boca PharmacalEndo Health SolutionsGenericsMergers & AcquisitionsPharmaceutical

Pharmstandard commits $30 million to Argos Therapeutics; post 1st-half results


Russia's largest drugmaker Pharmstandard (PHST: RU) that its subsidiary Pharmstandard International.(Luxembourg)…

AGS-003Argos TherapeuticsFinancialGenericsOncologyPharmaceuticalPharmstandardResearch

Aid group urges countries not to trade away health as TPP negotiations intensify


The far-reaching Trans-Pacific Partnership Agreement (TPP) should be a force for improving health outcomes…


Horizon Pharma in Duexis patent settlement


Horizon Pharma (Nasdaq: HZNP) says it has entered into settlement and license agreements with Par Pharmaceutical…

Anti-Arthritics/RheumaticsDuexisGenericsHorizon PharmaNorth AmericaPar PharmaceuticalPatentsPharmaceutical

US FDA accepts Pennsaid 2% NDA for review


The US Food and Drug Administration has accepted for filing US drugmaker Mallinckrodt's (NYSE: MNK) New…

Anti-Arthritics/RheumaticsGenericsMallinckrodtNorth AmericaNuvo ResearchPennsaidPharmaceuticalRegulation

Stada Arz buys UK OTC manufacturer


German generic and branded drugmaker Stada Arzneimittel (SAZ: GR) signed and concluded a contract for…

FinancialGenericsMergers & AcquisitionsPharmaceuticalSTADA ArzneimittelThornton & Ross

FTC submits proposed Amicus Brief on "No-Authorized-Generic" commitments in drug patent settlements


The US Federal Trade Commission has asked the US District Court for the District of New Jersey to accept…

ActavisEffexor XRGenericsLegalNorth AmericaPfizerPharmaceuticalTeva Pharmaceutical IndustriesWyeth

Japan's MHLW approves 367 generics, but what does this mean?


Japan's Ministry of Health Labor and Welfare (MHLW) approved 367 items of generic drugs last week. Launch…


Hikma first half EPS beats expectations; raises guidance


Jordan-headquartered drugmaker Hikma Pharmaceuticals (HIK: LSE) this morning (August 21) reported financial…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

Proposed Bill for South Africa Health Products Regulatory Authority


The South African Minister of Health has published the proposed amendments to the Medicines and Related…

GenericsPharmaceuticalRegulationRest of the World

BPH drug doesn't increase risk of death, but does save men from prostate cancer


A long-term follow-up to a groundbreaking study led by the director of the Cancer Therapy & Research…

finasterideGenericsMen's HealthMerck & CoOncologyPharmaceuticalProscarResearch

Avanir agrees settlement with Sandoz over Nuedexta


US drugmaker Avanir Pharmaceuticals (Nasdaq: AVNR) has entered into a settlement agreement with Swiss…

Avanir PharmaceuticalsGenericsLicensingNeurologicalNorth AmericaNuedextaPharmaceuticalSandoz

Two more drug patents revoked in India


In another blow for intellectual property in India, local drugmaker Ajanta Pharma has prevailed in revoking…

Ajanta PharmaAllerganAsia-PacificCombiganGanfortGenericsOphthalmicsPatentsPharmaceutical

New lab hopes to attract Western pharma for preclinical studies in Russia


One of Russia's largest laboratories for preclinical studies of drugs will soon be opened in the Vsevologsk…

Dom of PharmacyEuropeGenericsPharmaceuticalResearch

Japanese government committee has kicked off reform on drug pricing system


Revision of drug pricing rules in Japan gained momentum when the Council of Regulatory Reforms (CRR)…


Pharma associations strongly support Senate bill on FDA User Fees sequestration exemptions


In the USA last week, Mark Pryor (Democrat, Arkansas), chairman of the Senate Appropriations Subcommittee…

BiotechnologyFinancialGenericsLegalNorth AmericaPharmaceuticalPolitics

Teva Pharma sees slowdown in generic revenues


Israel-based Teva Pharmaceutical Industries (NYSE: TEVA), the world largest generics firm but with a…

CopaxoneFinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Actavis debuts new formulations of Fioricet


US generics major Actavis (NYSE: ACT) has launched new formulations of Fioricet (butalbital, acetaminophen…

AcetaminophenActavisFioricetFioricet with CodeineGenericsMarkets & MarketingNeurologicalNorth AmericaPharmaceutical

51 to 75 of 442 results

Back to top